REMINDER: Our user survey closes on Friday, please submit your responses here

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksIconic Labs Regulatory News (ICON)

  • This share is currently suspended. It was suspended at a price of 5.375

Share Price Information for Iconic Labs (ICON)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 5.375
Bid: 0.00
Ask: 0.00
Change: 0.00 (0.00%)
Spread: 0.00 (0.00%)
Open: 0.00
High: 0.00
Low: 0.00
Prev. Close: 5.375
ICON Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Statement re Dispute with Greencastle

14 Apr 2021 07:00

RNS Number : 3674V
Iconic Labs PLC
14 April 2021
 

14 April 2021

 

Iconic Labs Plc ("Iconic Labs" or the "Company")

 

Dispute with Greencastle Acquisition and others and investigation of former directors' conduct

 

Iconic Labs Plc (LSE:ICON), a multidivisional new media and technology business, announces that it has received (i) a statutory demand served by Greencastle Acquisition Limited for an amount (£58,668) alleged to be comprised of various sums assigned by John Quinlan, Liam Harrington and Samuel Regan Asante (the "Former Directors"), David Sefton, Matthew Vincent and Chris Pye less amounts owed by Greencastle entities to Iconic, including a £1,000,000 loan and management services fees; and (ii) a letter of demand from David Sefton claiming the amount of £256,676, allegedly comprising certain unpaid invoices. Such claims, which the Company believes are wholly without merit, will be vigorously defended by the Company in their entirety.

 

The Company has today sent a pre-action letter to Greencastle Acquisition Limited, Greencastle MM LLP, Greencastle Capital Limited, Linton Capital LLP and David Sefton, outlining a number of serious wrongdoings, including breaches of duty. Should the Company not receive a satisfactory response, the Company intends to issue proceedings in the Commercial Court in London.

 

The Company has also appointed forensic accounting and legal experts to assist with its investigation into further allegations of wrongdoing against the Former Directors and David Sefton.

Market Abuse Regulation (MAR) Disclosure

The information contained within this announcement is deemed by the Company to constitute inside information for the purposes of the Market Abuse Regulation (EU) No. 596/2014. Upon the publication of this announcement via a Regulatory Information Service, this inside information is now considered to be in the public domain.

**ENDS**

For further information, please visit the Company's website www.iconiclabs.co.uk or contact:

Iconic Labs ir@iconiclabs.co.uk

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
STRDKNBQCBKDDQD
Date   Source Headline
15th Mar 20234:35 pmRNSPrice Monitoring Extension
15th Mar 20232:05 pmRNSSecond Price Monitoring Extn
15th Mar 20232:00 pmRNSPrice Monitoring Extension
15th Mar 20239:05 amRNSSecond Price Monitoring Extn
15th Mar 20239:00 amRNSPrice Monitoring Extension
10th Mar 202311:05 amRNSSecond Price Monitoring Extn
10th Mar 202311:00 amRNSPrice Monitoring Extension
2nd Mar 20234:35 pmRNSPrice Monitoring Extension
28th Feb 20232:05 pmRNSSecond Price Monitoring Extn
28th Feb 20232:00 pmRNSPrice Monitoring Extension
28th Feb 20237:57 amRNSChange of Registered Office
28th Feb 20237:56 amRNSTotal Voting Rights
24th Feb 20234:35 pmRNSPrice Monitoring Extension
22nd Feb 20232:05 pmRNSSecond Price Monitoring Extn
22nd Feb 20232:00 pmRNSPrice Monitoring Extension
22nd Feb 20239:05 amRNSSecond Price Monitoring Extn
22nd Feb 20239:00 amRNSPrice Monitoring Extension
21st Feb 20234:40 pmRNSSecond Price Monitoring Extn
21st Feb 20234:35 pmRNSPrice Monitoring Extension
21st Feb 20232:05 pmRNSSecond Price Monitoring Extn
21st Feb 20232:00 pmRNSPrice Monitoring Extension
20th Feb 20234:35 pmRNSPrice Monitoring Extension
20th Feb 20237:49 amRNSDirector Appointment
16th Feb 20239:05 amRNSSecond Price Monitoring Extn
16th Feb 20239:00 amRNSPrice Monitoring Extension
15th Feb 20233:00 pmRNSTR-1 notification
15th Feb 20233:00 pmRNSTR-1 notification
15th Feb 20233:00 pmRNSTR-1 notification
15th Feb 20233:00 pmRNSTR-1 notification
15th Feb 20233:00 pmRNSTR1 notification
15th Feb 20233:00 pmRNSTR1 notification
10th Feb 20232:05 pmRNSSecond Price Monitoring Extn
10th Feb 20232:00 pmRNSPrice Monitoring Extension
10th Feb 20239:05 amRNSSecond Price Monitoring Extn
10th Feb 20239:00 amRNSPrice Monitoring Extension
10th Feb 20237:00 amRNSSubscription of Convertible Notes
9th Feb 20232:00 pmRNSPrice Monitoring Extension
9th Feb 20231:04 pmRNSConversion of Securities
8th Feb 20234:40 pmRNSSecond Price Monitoring Extn
8th Feb 20234:35 pmRNSPrice Monitoring Extension
8th Feb 20232:05 pmRNSSecond Price Monitoring Extn
8th Feb 20232:00 pmRNSPrice Monitoring Extension
6th Feb 20237:18 amRNSConversion of Notes
2nd Feb 20237:55 amRNSRestructuring Update
31st Jan 20232:05 pmRNSSecond Price Monitoring Extn
31st Jan 20232:00 pmRNSPrice Monitoring Extension
31st Jan 202311:05 amRNSSecond Price Monitoring Extn
31st Jan 202311:00 amRNSPrice Monitoring Extension
31st Jan 20238:52 amRNSTotal Voting Rights
30th Jan 20234:40 pmRNSSecond Price Monitoring Extn

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.